Vision Expo East 2024: Technological advancements and excellence in treatment collide

Commentary
Video

Laura Periman, MD, talks through what was gained from the conference, from becoming acquainted with new technological advancements to renewing passion for dry eye care.

For some eye care providers, the sheer amount of technological innovation available for treating patients may be overwhelming. Laura Periman, MD, talks through modern treatment options as an opportunity to get specific and passionate, as well as what role Vision Expo East 2024 plays in showcasing these new developments.

Video transcript

Editor's note - This transcript has been edited for clarity.

Laura Periman, MD:

Hi everyone, Laura Periman, Seattle, Washington. I'm the founder and director of Dry Eye Services and Clinical Research at the Periman Eye Institute in Seattle, Washington. We're here at Vision Expo East, the last year that it's going to be in New York City at the Javits Center. But I'm also here to continue to learn and continue to share with our colleagues, we had 2 fantastic sessions this morning, 1 on ocular surface disease complex cases, the other 1 on dry eye disease (my favorite topic), and we have a lot of fun talking about all the innovations that are coming about.

I think 2024 is going to continue to show us wonderful innovations and strides for our patients, learning as a community, best tools to use when and where, what situations, really learning from each other best critical practices; how to take advantage of all these incredible technologies, pharmacologics that we have available for us. When you come to a meeting, like this with Vision Expo, where you have nuts and bolts, beautiful equipment, advanced therapeutics, diagnostics, devices for treating, I think you walk away with a sense of renewed interest and passionate engagement with what you're doing Monday through Friday in the clinical lane. And the power it gives you to say to your patients that you're encountering next week, "I just saw this really interesting innovation at this convention that I was at this past weekend and I want to tell you a little bit about it." That kind of continuing education, integrating it into our everyday clinical practices, advanced learning, are really, I think, the cornerstones that keep us engaged as lifelong learners and doctors who really want the very best for our patients.

I think, for our colleagues out there, they get a little overwhelmed, maybe, at all of the innovations that we have in dry eye, I have good news for you: what's happening is we're gaining specific tools for specific jobs. So instead of just treating general categories of things, we now have direct arrows from the quiver that we can pull for exact clinical situations. That's empowering. Now we can untangle that ball of yarn that's each individual dry eye patient's clinical scenario, with precision, with mindfulness, with even more excellence than ever before.

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.